Incyte Ownership

Incyte has a total of 192.65 Million outstanding shares. The majority of Incyte outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Incyte to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Incyte. Please pay attention to any change in the institutional holdings of Incyte as this could imply that something significant has changed or is about to change at the company. On October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Incyte's common stock. Some institutional investors establish a significant position in stocks such as Incyte in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Incyte, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to rise to about 31.8 M in 2024. Dividend Paid And Capex Coverage Ratio is likely to rise to 10.98 in 2024. Net Income Applicable To Common Shares is likely to rise to about 411.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 130.7 M in 2024. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.